Global Nicotine Gum Market Outlook Report, 2019-2023 - The Growing Enrolment in Smoking Cessation Therapies is Driving Growth - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Feb 7, 2019--The “Global Nicotine Gum Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.
The nicotine gum market will register a CAGR of over 5% by 2023.
Increase in number of people quitting smoking to drive market growth
It is estimated that tobacco will cause more than 8 million deaths annually by 2030. In the US, cigarette smoking is responsible for nearly 480,000 deaths every year.
The number of quit attempts it takes before smokers are successful at quitting smoking varies. According to the American Cancer Society, it takes about 8-10 quit attempts, while the Australian Cancer Council suggests that it takes 12-14 attempts to quit the habit of smoking.
Growing enrolment in smoking cessation therapies
The smoking cessation therapy is gaining popularity among consumers who are trying to quit smoking, and in certain countries, governments are sponsoring smoking cessation therapy programs.
In the US, Department of Health and Human Services is sponsoring tobacco cessation programs through its supported health centers. Thus, the increasing application of nicotine gums as a medium to help consumers quit smoking will help in the growth of the global nicotine gums market during the forecast period.
Presence of substitute products
The availability of many substitute products can negatively influence the growth of the market during the forecast period. Nicotine patches, nicotine snus, nasal sprays, inhalers, and lozenges are some of the substitutes to nicotine gum. The emergence of e-cigarettes has considerably challenged the growth of the market.
The market appears to be fragmented, and with the presence of several companies including GlaxoSmithKline and ITC Limited, the competitive environment is quite intense.
Key PlayersBritish American Tobacco GlaxoSmithKline ITC Limited Johnson & Johnson Services Novartis
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPEMarket ecosystem Market characteristics Market segmentation analysis
PART 04: MARKET SIZINGMarket definition Market sizing 2018 Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSISBargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition
PART 06: MARKET SEGMENTATION BY PRODUCTComparison by product 2-mg nicotine - Market size and forecast 2018-2023 4-mg nicotine - Market size and forecast 2018-2023 Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPEGeographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 APAC - Market size and forecast 2018-2023 South America - Market size and forecast 2018-2023 MEA - Market size and forecast 2018-2023 Key leading countries Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDSNew product launches Increase in number of people quitting smoking Addiction to nicotine gums
PART 12: VENDOR LANDSCAPEOverview Landscape disruption
PART 13: VENDOR ANALYSISVendors covered Vendor classification Market positioning of vendors British American Tobacco GlaxoSmithKline ITC Limited Johnson & Johnson Services Novartis
For more information about this report visit https://www.researchandmarkets.com/research/6l4nj4/global_nicotine?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190207005690/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Over the Counter (OTC) Drugs,Addiction Disorders Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL RETAIL TOBACCO
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 02/07/2019 12:46 PM/DISC: 02/07/2019 12:46 PM